Stocks · Health care · Pharmaceutical Preparations

Wave Life Sciences, Inc.

WVE Clue Score51
United States Fiscal year ends December CIK 0001631574 Results filed 27 Oct 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Gregory L. Verdine
7 Mar 2025
Director
Exercised, kept
133,402
$2.48
$330.84K
Gregory L. Verdine
5 Mar 2025
Director
Exercised, kept
133,000
$2.48
$329.84K
Chandra Vargeese
4 Mar 2025
See Remarks
Exercised, kept
91,754
$2.48
$227.55K
Chandra Vargeese
23 Jan 2025
See Remarks
Exercised, kept
46,000
$2.48
$114.08K
Kyle Moran
11 Oct 2024
Chief Financial Officer
Exercised, kept
25,000
$2.48
$62.00K
Chandra Vargeese
22 Jul 2024
See Remarks
Exercised, kept
68,210
$2.48
$169.16K
Kyle Moran
24 Mar 2021
Chief Financial Officer
Exercised, kept
10,930
$2.48
$27.11K
Roberto Guerciolini
7 Dec 2016
See Remarks
Exercised, kept
4,000
$2.47
$9.88K
Roberto Guerciolini
7 Dec 2016
See Remarks
Exercised, kept
20,000
$2.47
$49.40K

What was left out

Form 4 filings counted 234
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 15
Sales on a Rule 10b5-1 plan 20
Sales straight out of an exercise 74
Sales at will 50
Transactions with no price 0
Shares from compensation/vesting 9,171,525
Sales filed before the plan box existed 46
History held since 18 Nov 2015